TUESDAY, Nov. 12, 2024 (HealthDay News) — Beta blockers are go-to meds for many people who’ve survived a heart attack. However, new Swedish research has found that they might not be needed for heart attack survivors whose hearts have retained a normal pumping ability.  Using them in this group mightContinue Reading

MONDAY, Nov. 11, 2024 (HealthDay News) — People with both type 2 diabetes and chronic kidney disease face a heart health double-whammy, a new study says. Men with both diabetes and kidney disease will develop heart health problems 28 years earlier than those without either condition, researchers reported today atContinue Reading

MONDAY, Nov. 11, 2024 (HealthDay News) — Thousands of Americans with heart trouble have small implanted defibrillators, to help regulate their heartbeat and keep cardiac events at bay.  But new research finds that on extremely hot days, people with the devices face nearly triple the odds for a dangerous arrhythmiaContinue Reading

MONDAY, Nov. 11, 2024 (HealthDay News) — Lives lost to obesity-related heart disease have nearly tripled over the past twenty years, a new study reports. Heart disease deaths linked to obesity increased 2.8-fold between 1999 and 2020, according to findings presented today at the American Heart Association’s annual meeting inContinue Reading

TUESDAY, Oct. 22, 2024 (HealthDay News) — Heart bypass operations have gotten safer, but not everyone is benefiting equally: New data shows that Black patients face a 22% higher odds of dying in the hospital after their surgeries. “We found Black patients who have coronary artery bypass surgery experience higherContinue Reading

THURSDAY, Oct. 17, 2024 (HealthDay News) — Doctors might be overprescribing sedatives to stroke survivors, a new study warns. About 5% of people are prescribed a benzodiazepine following a stroke, to help calm anxiety and improve sleep, researchers found. Benzodiazepine meds include Valium, Ativan and Xanax. But these prescriptions oftenContinue Reading

THURSDAY, Oct. 17, 2024 (HealthDay News) — An off-label clot-busting drug appears to work slightly better in treating stroke patients than an approved medication, a new review finds. The clot-buster tenecteplase is associated with a slightly higher likelihood of excellent recovery and reduced disability three months following a stroke, comparedContinue Reading